These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 30090884)

  • 1. Responsive upconversion nanoprobe for monitoring and inhibition of EBV-associated cancers via targeting EBNA1.
    Zha S; Fung YH; Chau HF; Ma P; Lin J; Wang J; Chan LS; Zhu G; Lung HL; Wong KL
    Nanoscale; 2018 Aug; 10(33):15632-15640. PubMed ID: 30090884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus-encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV-carrying cancers.
    Daskalogianni C; Pyndiah S; Apcher S; Mazars A; Manoury B; Ammari N; Nylander K; Voisset C; Blondel M; Fåhraeus R
    J Pathol; 2015 Jan; 235(2):334-41. PubMed ID: 25186125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-Targeting Peptide-Guided Approach for Precision Delivery and Cancer Monitoring by Using a Safe Upconversion Nanoplatform.
    Zha S; Chau HF; Chau WY; Chan LS; Lin J; Lo KW; Cho WC; Yip YL; Tsao SW; Farrell PJ; Feng L; Di JM; Law GL; Lung HL; Wong KL
    Adv Sci (Weinh); 2021 Mar; 8(5):e2002919. PubMed ID: 33717845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance.
    Deakyne JS; Malecka KA; Messick TE; Lieberman PM
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
    Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
    J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EBNA1-specific luminescent small molecules for the imaging and inhibition of latent EBV-infected tumor cells.
    Jiang L; Lui YL; Li H; Chan CF; Lan R; Chan WL; Lau TC; Tsao GS; Mak NK; Wong KL
    Chem Commun (Camb); 2014 Jun; 50(49):6517-9. PubMed ID: 24821080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upconversion nanoparticles conjugated with Gd(3+) -DOTA and RGD for targeted dual-modality imaging of brain tumor xenografts.
    Jin J; Xu Z; Zhang Y; Gu YJ; Lam MH; Wong WT
    Adv Healthc Mater; 2013 Nov; 2(11):1501-12. PubMed ID: 23630101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of Epstein-Barr nuclear antigen 1 (EBNA1) by RNA interference inhibits proliferation of EBV-positive Burkitt's lymphoma cells.
    Hong M; Murai Y; Kutsuna T; Takahashi H; Nomoto K; Cheng CM; Ishizawa S; Zhao QL; Ogawa R; Harmon BV; Tsuneyama K; Takano Y
    J Cancer Res Clin Oncol; 2006 Jan; 132(1):1-8. PubMed ID: 16180023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EBNA1.
    Frappier L
    Curr Top Microbiol Immunol; 2015; 391():3-34. PubMed ID: 26428370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Epstein-Barr virus-like particles incorporating gH/gL-EBNA1 or gB-LMP2 induce high neutralizing antibody titers and EBV-specific T-cell responses in immunized mice.
    Perez EM; Foley J; Tison T; Silva R; Ogembo JG
    Oncotarget; 2017 Mar; 8(12):19255-19273. PubMed ID: 27926486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA ligand designed to antagonize EBNA1 represses Epstein-Barr virus-induced immortalization.
    Yasuda A; Noguchi K; Minoshima M; Kashiwazaki G; Kanda T; Katayama K; Mitsuhashi J; Bando T; Sugiyama H; Sugimoto Y
    Cancer Sci; 2011 Dec; 102(12):2221-30. PubMed ID: 21910783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies.
    Sivachandran N; Sarkari F; Frappier L
    PLoS Pathog; 2008 Oct; 4(10):e1000170. PubMed ID: 18833293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EBV-encoded EBNA1 regulates cell viability by modulating miR34a-NOX2-ROS signaling in gastric cancer cells.
    Kim SM; Hur DY; Hong SW; Kim JH
    Biochem Biophys Res Commun; 2017 Dec; 494(3-4):550-555. PubMed ID: 29061308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus nuclear antigen 1 interacts with Nm23-H1 in lymphoblastoid cell lines and inhibits its ability to suppress cell migration.
    Murakami M; Lan K; Subramanian C; Robertson ES
    J Virol; 2005 Feb; 79(3):1559-68. PubMed ID: 15650182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eradication of Epstein-Barr virus episome and associated inhibition of infected tumor cell growth by adenovirus vector-mediated transduction of dominant-negative EBNA1.
    Nasimuzzaman M; Kuroda M; Dohno S; Yamamoto T; Iwatsuki K; Matsuzaki S; Mohammad R; Kumita W; Mizuguchi H; Hayakawa T; Nakamura H; Taguchi T; Wakiguchi H; Imai S
    Mol Ther; 2005 Apr; 11(4):578-90. PubMed ID: 15771960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The EBNA1 protein of Epstein-Barr virus functionally interacts with Brd4.
    Lin A; Wang S; Nguyen T; Shire K; Frappier L
    J Virol; 2008 Dec; 82(24):12009-19. PubMed ID: 18922874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Epstein-Barr nuclear antigen 1 in gastric carcinoma cells is associated with enhanced tumorigenicity and reduced cisplatin sensitivity.
    Cheng TC; Hsieh SS; Hsu WL; Chen YF; Ho HH; Sheu LF
    Int J Oncol; 2010 Jan; 36(1):151-60. PubMed ID: 19956844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGCG debilitates the persistence of EBV latency by reducing the DNA binding potency of nuclear antigen 1.
    Chen YL; Tsai HL; Peng CW
    Biochem Biophys Res Commun; 2012 Jan; 417(3):1093-9. PubMed ID: 22226960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RGD peptide-conjugated multimodal NaGdF4:Yb3+/Er3+ nanophosphors for upconversion luminescence, MR, and PET imaging of tumor angiogenesis.
    Lee J; Lee TS; Ryu J; Hong S; Kang M; Im K; Kang JH; Lim SM; Park S; Song R
    J Nucl Med; 2013 Jan; 54(1):96-103. PubMed ID: 23232276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc finger E-box binding factor 1 plays a central role in regulating Epstein-Barr virus (EBV) latent-lytic switch and acts as a therapeutic target in EBV-associated gastric cancer.
    Zhao J; Jin H; Cheung KF; Tong JH; Zhang S; Go MY; Tian L; Kang W; Leung PP; Zeng Z; Li X; To KF; Sung JJ; Yu J
    Cancer; 2012 Feb; 118(4):924-36. PubMed ID: 21717425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.